Baxter International (BAX) Expected to Announce Earnings on Thursday

Key Points

• Baxter International is expected to report Q3 2026 results before Thursday’s market open. Analysts forecast earnings of $0.518 per share on $2.91 billion in revenue; the company’s FY 2026 EPS guidance is $1.95–$2.15.
• Baxter’s previous quarter exceeded expectations, with EPS of $0.56 versus the $0.37 consensus and revenue of $2.96 billion, up 5.3% year over year.
• Analyst sentiment remains cautious: the stock has a consensus “Reduce” rating and a $21.73 target price, below its reported share price of $24.74. Baxter also recently declared a $0.01 quarterly dividend, yielding approximately 0.2%.

Baxter International (NYSE:BAX - Get Free Report) is projected to announce its Q3 2026 results before the market opens on Thursday, October 29th. Analysts expect the company to announce earnings of $0.5180 per share and revenue of $2.91 billion for the quarter. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. Parties can find conference call details on the company's upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, October 29, 2026 at 8:30 AM ET.

Baxter International (NYSE:BAX - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.19. The company had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.80 billion. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%. The company's revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.59 EPS. On average, analysts expect Baxter International to post $2.04 EPS for the current fiscal year and $2.00 EPS for the next fiscal year.

Baxter International Stock Up 1.0%

Shares of NYSE BAX opened at $24.74 on Thursday. The company has a market cap of $12.79 billion, a price-to-earnings ratio of 11.96, a PEG ratio of 3.71 and a beta of 0.65. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39. Baxter International has a 12 month low of $15.73 and a 12 month high of $30.00. The stock has a 50-day moving average price of $24.81 and a two-hundred day moving average price of $22.06.

Baxter International Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Friday, August 28th were given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date was Friday, August 28th. Baxter International's dividend payout ratio is currently -1.93%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on BAX shares. Wolfe Research began coverage on shares of Baxter International in a research report on Tuesday. They issued a "peer perform" rating on the stock. The Goldman Sachs Group upped their price target on shares of Baxter International from $19.00 to $21.00 and gave the stock a "neutral" rating in a report on Wednesday, July 15th. Wells Fargo & Company increased their price target on Baxter International from $19.00 to $23.00 and gave the company an "equal weight" rating in a research note on Friday, July 31st. Weiss Ratings downgraded Baxter International from a "sell (d)" rating to a "sell (d-)" rating in a report on Thursday, October 8th. Finally, TD Cowen raised their price objective on Baxter International from $20.00 to $24.00 and gave the company a "hold" rating in a report on Monday, July 27th. One analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Reduce" and a consensus target price of $21.73.

Baxter International Company Profile

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter's portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.